Nursing care
Cardiomyopathy nursing care: what to assess and what to do first
Written and reviewed by Dana Whitfield, RN, MSN · 6 min read · Updated September 2026
Short answer
Cardiomyopathy nursing care depends on which of the three types you are dealing with, because dilated, hypertrophic and restrictive disease fail through entirely different mechanisms. Dilated cardiomyopathy is a pump that has stretched and weakened; hypertrophic is a muscle that has thickened and can obstruct its own outflow; restrictive is a chamber that has stiffened and cannot fill. Hypertrophic is the type most associated with sudden death in young, otherwise fit people.
Recognising it at the bedside
Dilated cardiomyopathy looks like classic systolic heart failure: an enlarged, thin-walled, poorly contracting left ventricle, an S3 gallop, a laterally displaced apical impulse, and the fatigue and dyspnoea of low ejection fraction. It is the most common of the three and often has an identifiable cause, viral myocarditis, alcohol, chemotherapy, or peripartum onset.
Hypertrophic cardiomyopathy looks deceptively well until it doesn't. The septum thickens asymmetrically, sometimes obstructing left ventricular outflow, and the patient can be a fit young adult with no prior diagnosis. Listen for a systolic murmur that increases with Valsalva or standing, the opposite of most murmurs, because reduced preload worsens the outflow obstruction. Restrictive cardiomyopathy looks like right-sided failure out of proportion to left ventricular size: a stiff, non-compliant myocardium that fills poorly, giving marked jugular venous distension, ascites and oedema with a heart that may not even look enlarged on exam.
Why the classic presentation misleads
Nurses trained to expect heart failure in older adults with known risk factors can miss hypertrophic cardiomyopathy entirely, because the typical patient is young, active, and asymptomatic until exertion triggers syncope, arrhythmia or sudden cardiac arrest. It is a leading cause of sudden death in young athletes, and a family history of unexplained sudden death in a relative under 40 is a red flag that deserves the same weight as a positive troponin.
Restrictive cardiomyopathy is easy to mistake for constrictive pericarditis or straightforward right heart failure, since the presenting picture, oedema, ascites, hepatomegaly, looks the same from the outside. The distinguishing feature is diastolic dysfunction with a normal or near-normal ejection fraction, so a preserved EF on echo does not rule out serious cardiac disease here. Dilated cardiomyopathy is the one presentation that matches what most nurses expect, which is exactly why the other two get missed or delayed.
Priority nursing actions
For dilated cardiomyopathy, manage as heart failure: daily weights, strict intake and output, oxygen and positioning for dyspnoea, and administer prescribed ACE inhibitors, beta-blockers and diuretics while monitoring for hypotension. Activity is titrated to tolerance rather than restricted outright, since deconditioning worsens outcomes.
For hypertrophic cardiomyopathy, avoid anything that reduces preload or afterload aggressively, dehydration, vigorous exercise, straining, and certain vasodilators, because all of these worsen outflow obstruction. Beta-blockers are typically first-line for symptom control precisely because they slow the heart and allow more filling time. Educate on avoiding competitive sport and on recognising exertional syncope as an emergency symptom, not a fainting spell to sleep off. For restrictive cardiomyopathy, manage volume overload cautiously since a stiff ventricle needs adequate filling pressure and can drop output if over-diuresed, mirroring the caution used in aortic stenosis. Monitor closely for conduction abnormalities in all three types.
Labs and diagnostics to expect
Echocardiography differentiates the three by wall thickness, chamber size and ejection fraction: dilated shows a large, thin-walled ventricle with low EF; hypertrophic shows asymmetric septal thickening with preserved or even elevated EF; restrictive shows normal or near-normal chamber size and EF with impaired diastolic filling. BNP or NT-proBNP is elevated in all three when volume status is deranged and tracks trend better than a single value.
Genetic testing and family screening are relevant specifically for hypertrophic cardiomyopathy, since it is frequently inherited in an autosomal dominant pattern, and first-degree relatives are typically offered screening echocardiograms. Cardiac MRI helps identify restrictive causes such as amyloidosis or sarcoidosis when echo findings are ambiguous. Troponin and viral serologies are relevant early in suspected dilated cardiomyopathy from myocarditis. Continuous telemetry matters across all three, since malignant arrhythmia is the pathway to sudden death in each, most acutely in hypertrophic disease.
Complications and their early signs
Sudden cardiac death from ventricular arrhythmia is the defining risk in hypertrophic cardiomyopathy, and exertional syncope, palpitations or a family history of sudden death should prompt urgent evaluation for an implantable cardioverter-defibrillator rather than reassurance. Outflow tract obstruction can also worsen acutely with dehydration or vasodilator use, so fluid status needs active protection, not just monitoring.
Dilated cardiomyopathy progresses toward refractory heart failure, mural thrombus formation in the dilated, poorly contracting chamber, and cardioembolic stroke; watch for a new focal neurological deficit as seriously as you would watch for worsening dyspnoea. Restrictive cardiomyopathy progresses toward atrial fibrillation, from atrial stretch against a stiff ventricle, and toward advancing right heart failure with worsening ascites and hepatic congestion. Across all three, escalating diuretic resistance or a new arrhythmia on telemetry signals that the disease has moved into a higher-risk phase.
Teaching that changes outcomes
For dilated cardiomyopathy, teach adherence to fluid and sodium restriction, daily weights, and the symptoms of worsening failure, exactly as for any heart failure discharge, alongside honest discussion of prognosis and, where relevant, advanced therapy options.
For hypertrophic cardiomyopathy, the single most outcome-changing piece of teaching is activity restriction: no competitive or high-intensity exercise, and immediate medical attention for exertional chest pain, palpitations or syncope rather than assuming it is benign. Screening for first-degree relatives should be raised explicitly, since this is inherited and asymptomatic relatives can be at risk without knowing it. For restrictive cardiomyopathy, teach the same fluid and weight monitoring as dilated disease, but add caution against over-restriction of fluids without medical guidance, since this ventricle depends on adequate filling pressure. Across all three types, teach the patient to name their specific type of cardiomyopathy to any new provider, because the safe treatment for one type can actively harm another.
The next step on this is the same as on everything else here: answer questions and read the rationales. Our cardiovascular practice questions are the closest set to what this page covers.
Common questions
Which type of cardiomyopathy causes sudden death in young athletes?
Hypertrophic cardiomyopathy is the type most associated with sudden cardiac death in young, apparently healthy athletes. The thickened septum can obstruct left ventricular outflow during exertion, triggering fatal arrhythmia, often in someone with no prior diagnosis. Family history of unexplained sudden death under 40 is a key screening flag.
Why should beta-blockers be used cautiously in hypertrophic cardiomyopathy but are standard in dilated cardiomyopathy?
Beta-blockers are first-line in hypertrophic cardiomyopathy because slowing the heart rate allows more diastolic filling time and reduces outflow obstruction. In dilated cardiomyopathy they are also standard, but titrated slowly and cautiously because the weakened ventricle can decompensate if negative inotropy is introduced too quickly.
How do you tell restrictive cardiomyopathy apart from constrictive pericarditis?
Both present with right-sided failure signs, jugular venous distension, ascites and oedema, but restrictive cardiomyopathy involves stiffened myocardium itself, while constrictive pericarditis involves a rigid pericardium constraining a normal heart muscle. Cardiac MRI or catheterisation is usually needed to distinguish them definitively, since the bedside picture overlaps closely.
What activity restriction is most important to teach in hypertrophic cardiomyopathy?
Avoiding competitive and high-intensity exercise is the single most important teaching point, since exertion can trigger fatal arrhythmia in a heart with outflow obstruction. Patients should also be told that exertional chest pain, palpitations or syncope are emergencies, not symptoms to rest through.
Is ejection fraction always low in cardiomyopathy?
No, and this is a frequent point of confusion. Ejection fraction is low in dilated cardiomyopathy but is often normal or even elevated in hypertrophic and restrictive cardiomyopathy, where the problem is filling rather than contraction. A normal EF on echo does not rule out serious cardiomyopathy.
More on cardiovascular
Guides on this